Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-01-24 @ 3:44 AM
Study NCT ID:
NCT03833661
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2019-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | M7824 | View |
| None | Bintrafusp alfa (proposed INN) | View |
| None | Transforming growth factor-beta | View |
| None | First-line Platinum-Based Chemotherapy | View |
| None | Programmed death-ligand 1 | View |
| None | Metastatic Biliary Tract Cancer | View |
| None | Cholangiocarcinoma | View |
| None | Gallbladder cancer | View |